Mediterranean Fever (MEFV) Peptide
MEFV
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN979970
Quick Overview for Mediterranean Fever (MEFV) Peptide (ABIN979970)
Target
MEFV
(Mediterranean Fever (MEFV))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-MEFV antibody (Catalog #: ARP32016_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MEFV (Mediterranean Fever (MEFV))
-
Background
-
MEFV was identified as the gene that when mutated causes Mediterranean fever, a hereditary periodic fever syndrome. MEFV is expressed in granulocytes and myeloid bone marrow precursors.
Alias Symbols: FMF, MEF, TRIM20
Protein Interaction Partner: COG5,PSTPIP1,PYCARD,COG5,PYCARD
Protein Size: 781 -
Molecular Weight
- 86 kDa
-
Gene ID
- 4210
-
NCBI Accession
- NM_000243, NP_000234
-
UniProt
- O15553
Target
-
You are here:
